Owiredu J, Ersoy-Fazlioglu B, Poluben L, Calagua C, et al. Increased ErbB2 signaling is an early adaptation to androgen signaling inhibition and persists in castration resistant prostate cancer. Clin Cancer Res 2025 Aug 12. doi: 10.1158/1078-0432.CCR-22-3683.
PMID: 40795068